Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new checkpoint that cells use to control what molecules they internalize. Understanding the determinants for entry into cells could lead to the design of better therapeutics that must enter through this gatekeeping mechanism.